Allied Health & Imaging · Independent exam preparation
Mammography Study Guide
Practise breast positioning, image-quality decisions, patient communication, and biopsy support with a focused guide aligned to ARRT's Mammography outline.
By CertMedbry · Updated 14 October 2026
Learn to recognize missing breast tissue, select additional views for a defined problem, distinguish suspicious imaging features, and support accurate diagnostic procedures. This guide follows ARRT's Mammography examination for certification and registration. Its 60 concepts are selective: the official examination content specifications define the full scope. The accompanying questions and flashcards develop reasoning across Patient Care, Image Production, and Procedures.
Try 20 free practice questionsWhat is the exam format?
Check the question types, timing and outline before planning your revision.
Which credential and eligibility pathway does this guide address?
It addresses ARRT certification and registration in Mammography through the postprimary eligibility pathway. ARRT's Mammography credential page identifies this pathway and requires an approved supporting credential, alongside the applicable education, ethics, clinical experience, and examination requirements. The workbook label 'ARRT Certification in Mammography (M)' refers to this same discipline.
Does the reference listing establish a separate primary-pathway Mammography examination?
The reference listing includes several handbook links, but that alone does not establish another Mammography examination or eligibility route. This guide follows the postprimary pathway explicitly described on ARRT's Mammography credential page. Breast Sonography and Magnetic Resonance Imaging are separate disciplines with their own specifications.
How many examination questions are scored and unscored?
The applicable specifications identify 115 scored questions and 30 additional unscored pilot questions, for 145 questions altogether. Study allocations should use the 115 scored questions as the denominator. The pilot questions do not contribute to those domain allocations.
What are the official domain allocations?
Patient Care has 20 scored questions, Image Production has 30, and Procedures has 65. Their calculated shares are approximately 17.39%, 26.09%, and 56.52%. Within Procedures, Anatomy, Physiology, and Pathology has 26 questions, while Mammographic Positioning and Procedures has 39. This guide contains 11, 16, and 33 concepts across the three domains; its questions and flashcards each contain 4, 5, and 11 items.
Which blueprint version applies?
The specifications were board approved in July 2024 and implemented September 1, 2025; the document identifier is V.2024.09.09. ARRT's reference listings checked October 13, 2026, show Mammography without a separately dated replacement examination specification. Check ARRT's current listing before your examination date, especially when scheduling well ahead.
ARRT: Mammography Examination Content Specifications · ARRT: Examination Content Specifications
What are the examination duration and delivery arrangements?
The 2026 ARRT postprimary handbook describes computer-based testing through Pearson. Mammography has 145 total items: 115 scored and 30 unscored pilots. Examination time is 150 minutes within a 170-minute appointment; the additional time covers the tutorial, nondisclosure agreement, and survey. ARRT describes mostly multiple-choice questions with one best answer, with possible multiple-response, ordering, image-selection, and video-associated questions. This general format description does not mean every format necessarily appears on Mammography. These practice questions each use four options and one best answer.
arrt-postprimary-handbook.pdf · ARRT: Mammography Examination Content Specifications
How should this guide be used with official requirements?
Use it to practise explanations and decisions, then check every topic against the full official examination outline. Structured education and clinical experience requirements are separate documents and are not interchangeable with the examination blueprint. Practice performance identifies learning needs; it does not predict an ARRT passing result.
Mammography is a specialized Registered Technologist discipline. This guide addresses the mammographer's knowledge and decisions, including U.S. MQSA requirements where applicable. It is independently authored educational material; ARRT establishes the examination identity and blueprint.
Outline used: Mammography Examination Content Specifications, board approved July 2024, implemented September 1, 2025, document V.2024.09.09. The workbook label 'ARRT Certification in Mammography (M)' maps to ARRT's examination for certification and registration in Mammography; the assigned slug is preserved.
60 key concepts: understand, apply and avoid the traps
Work through the questions by exam domain. Explain the answer in your own words, try the example, then check the common pitfall.
Patient Care17.39% (20 of 115 scored questions)
1.When does a breast symptom require diagnostic rather than screening evaluation?
Screening mammography examines people without breast symptoms for otherwise unsuspected disease. Diagnostic mammography investigates a clinical concern or an abnormal screening finding and may require tailored views or complementary imaging. A new palpable lump, nipple discharge, or skin change changes the examination's purpose even when the appointment was originally booked as screening. The decisive distinction is the indication, rather than the patient's age or the equipment used.
Apply it
A patient arriving for annual screening reports a new left breast lump. Document its location and onset, communicate the change to the appropriate clinical team, and arrange diagnostic evaluation rather than silently completing the original screening workflow.
Common pitfall: A screening appointment label does not override a newly disclosed symptom. A normal previous mammogram also does not establish the cause of a current lump.
2.What history makes a breast imaging concern clinically useful?
Useful history links the examination to a specific concern: laterality, location, onset, change over time, prior breast procedures, personal or family cancer history, hormone use, and possible pregnancy. These details help distinguish a new finding from an expected postoperative change and guide correlation with images. Record the patient's description accurately without converting it into a diagnosis. A precise location and timeline are more useful than an unexplained entry such as 'breast problem.'
Apply it
A patient reports discomfort near an old surgical scar. Record which breast, the scar location, the operation and approximate date, and whether the discomfort is new. Give the interpreting team enough information to correlate the concern with imaging.
Common pitfall: Do not assume every finding near a scar is postoperative. History helps interpretation but cannot independently establish that a new abnormality is benign.
3.Why are prior images more informative than a remembered normal result?
Prior images allow direct comparison of the same tissue over time, including masses, calcifications, asymmetries, and postoperative changes. A report provides conclusions but may not show the precise appearance or position of a finding. Comparison can demonstrate stability or identify a developing change. Obtain the actual previous imaging when available and confirm that it belongs to the correct patient and examination; a remembered 'normal' result cannot provide this anatomical comparison.
Apply it
A patient changed facilities and recalls a benign right breast finding. Request the previous images and report for comparison. Explain that the images help the radiologist determine whether today's finding matches the previously assessed area.
Common pitfall: Stability is evidence for interpretation, not a technologist's independent diagnosis. Missing prior images must not be concealed or replaced with the patient's recollection.
ACR/RSNA RadiologyInfo: How to Read Your Breast Imaging Report Using BI-RADS
4.How does a clear compression explanation improve cooperation?
Compression spreads overlapping tissue, reduces breast thickness and scatter, and limits movement during exposure. These effects improve image quality while allowing less radiation than would otherwise be needed for a thicker breast. Explain what the patient will feel, why the pressure matters, and that each exposure is brief. Connecting the sensation to a concrete imaging benefit helps the patient participate in positioning and stillness rather than treating compression as an unexplained obstacle.
Apply it
A patient asks why the paddle must press firmly. Explain that flattening the breast separates tissue and holds it still, then describe the short exposure. Invite the patient to report pain while you apply compression gradually.
Common pitfall: Saying that compression is necessary without explaining its benefits can increase anxiety. Promising a painless examination is also inaccurate because individual sensitivity varies considerably.
5.How should pain and anxiety change the positioning interaction?
Pain can cause guarding or movement, while anxiety can make positioning instructions difficult to follow. Establish what concerns the patient, explain one action at a time, and apply compression gradually while monitoring tolerance. If discomfort is significant, reassess positioning and compression rather than forcing the same approach. The aim is adequate tissue inclusion and immobilization with tolerable pressure. Communication is therefore part of image acquisition, not merely a courtesy before it.
Apply it
An anxious patient tenses her shoulder as compression increases. Pause, explain the next movement, help her relax the shoulder, and reposition before continuing. Reassess pain so that guarding does not repeatedly compromise posterior tissue inclusion.
Common pitfall: Increasing pressure against a poorly positioned, tense patient may worsen pain and motion. Conversely, abandoning adequate immobilization without reassessment can leave the images diagnostically limited.
6.When should possible pregnancy be identified before mammography?
Possible pregnancy should be disclosed before exposure because mammography uses ionizing x-rays and the clinical indication needs appropriate review. Obtain the relevant history and communicate it through the facility's clinical process. Pregnancy does not itself establish that a breast symptom should be ignored or that every mammographic examination must be cancelled. The imaging decision depends on the clinical question and suitable alternatives; the technologist should identify the issue rather than invent a universal rule.
Apply it
A patient with a breast concern says her period is late and pregnancy is possible. Before exposure, document the disclosure and alert the responsible clinician so the indication and imaging approach can be reviewed.
Common pitfall: Do not assume that pregnancy is impossible from appearance or age. Do not substitute an automatic cancellation for clinical review of a potentially important breast symptom.
7.Why can deodorant and powder interfere with mammographic assessment?
Deodorant, talcum powder, and some lotions can produce visible material on mammograms that may resemble calcium deposits or obscure assessment. Preparation instructions should therefore include avoiding these products on the breasts and underarms on examination day. If a patient has already applied them, explain the reason for cleaning the area before imaging. This addresses an external source of artifact rather than assuming every bright focus originates within breast tissue.
Apply it
A patient reports applying powder beneath both breasts. Provide a way to clean the relevant skin before positioning and explain that powder can create misleading image findings. Check that residual material is removed before exposure.
Common pitfall: An external artifact should not be dismissed as harmless merely because its cause seems familiar. Residue can still interfere with interpretation and lead to unnecessary additional imaging.
8.What written-result duties apply under current U.S. MQSA rules?
For facilities subject to U.S. MQSA, patients must receive an understandable written summary of mammography results within 30 calendar days of the examination. When the final interpretation is 'Suspicious' or 'Highly Suggestive of Malignancy,' the written summary is required within seven calendar days of that interpretation. Verbal communication does not replace the written summary. Current requirements also include breast density information, helping patients understand both masking and risk implications.
Apply it
A patient is telephoned after a suspicious final interpretation. Verify that the required written summary is also issued within the applicable seven-calendar-day interval and that the follow-up process is clear to the patient.
Common pitfall: Do not apply the ordinary 30-day interval to suspicious interpretations. Also distinguish the examination date from the final-interpretation date when identifying the relevant deadline.
9.How do BI-RADS assessments connect findings to follow-up?
BI-RADS provides a common assessment language with associated management. Category 0 means the evaluation is incomplete and needs additional imaging or comparison. Category 1 is negative, category 2 describes benign findings, and category 3 indicates a probably benign finding suitable for short-interval surveillance. Categories 4 and 5 support tissue diagnosis because concern is greater; category 6 identifies known biopsy-proven malignancy. Explain the assigned recommendation without treating the category as your own diagnosis.
Apply it
A patient sees 'BI-RADS 0' and assumes cancer has been diagnosed. Explain that the assessment is incomplete and additional evaluation is needed. Help the patient understand the recommended next examination and how to arrange it.
Common pitfall: Incomplete assessment is not synonymous with malignancy. Probably benign is also different from definitively benign and should not be translated into permission to skip follow-up.
ACR/RSNA RadiologyInfo: How to Read Your Breast Imaging Report Using BI-RADS
10.What distinguishes lumpectomy from removal of the entire breast?
Lumpectomy is breast-conserving surgery that removes the cancer or abnormal area together with surrounding normal tissue while retaining most of the breast. Mastectomy removes the breast rather than only the localized area. Radiation therapy commonly follows lumpectomy, and other treatments depend on the disease and patient. Recognizing the operation helps explain scars, altered breast contour, and treatment history, but does not establish that every subsequent imaging change is an expected postoperative finding.
Apply it
A patient says she had 'the lump removed' followed by radiation. Clarify the operation and treatment dates, document the history, and obtain prior images so the radiologist can evaluate the treated area accurately.
Common pitfall: Do not equate lumpectomy with absence of future breast imaging needs. Retained breast tissue and new symptoms still require appropriate assessment through the treatment and imaging team.
40.Why is prior therapeutic chest radiation relevant to breast cancer risk?
Radiation therapy to the chest, particularly at a young age, is associated with increased subsequent breast cancer risk. This history differs from routine low-dose mammographic exposure and should be recorded accurately, including the treatment context and timing when known. It contributes to the patient's overall risk assessment and may affect clinician-directed screening planning. A risk factor increases probability; it neither diagnoses a current cancer nor determines one universal imaging schedule for every patient.
Apply it
An adult patient reports chest radiation for lymphoma during adolescence. Document that therapeutic exposure and communicate it to the risk-assessment team rather than treating it as equivalent to a history of ordinary chest radiographs.
Common pitfall: Do not collapse therapeutic radiation and routine diagnostic imaging into the same risk category. Also avoid inventing a screening schedule from this single history detail.
Image Production26.09% (30 of 115 scored questions)
11.How do beam energy and filtration affect breast imaging?
Beam quality depends on the tube potential and target-filter combination, which shape the energies reaching the breast. More penetrating spectra can improve transmission through thicker tissue, while lower-energy spectra provide greater subject contrast but may increase absorption. Filtration removes portions of the spectrum that contribute inefficiently to imaging. Technique selection balances penetration, contrast, noise, and dose; a single target-filter combination or tube potential cannot be treated as optimal for every breast and digital system.
Apply it
A thicker breast requires more penetration than the preceding thin breast. Review the system's selected acquisition technique and exposure information rather than forcing identical settings solely because both examinations use the same standard projection.
Common pitfall: Higher penetration is not automatically better image quality. Technique must preserve adequate contrast and signal while avoiding unnecessary dose or excessive exposure time for the clinical task.
12.What does half-value layer measure?
Half-value layer is the thickness of a specified attenuating material needed to reduce beam intensity to one-half under the stated measurement conditions. It characterizes beam quality rather than focal-spot size or image brightness. A greater half-value layer generally indicates a more penetrating beam when the material and measurement conditions are comparable. Its interpretation belongs with the selected spectrum and applicable equipment requirements; it is not a direct measurement of absorbed glandular dose.
Apply it
During a physics discussion, one beam needs a thicker aluminum layer than another to halve its measured intensity. With otherwise comparable conditions, identify the first beam as more penetrating rather than describing it as sharper.
Common pitfall: Do not interpret half-value layer as the amount of breast compression or as half the patient dose. It describes attenuation of the beam in a measurement setup.
IAEA: Quality Assurance Programme for Screen Film Mammography
13.Why does focal-spot size matter more when geometric magnification increases?
A finite focal spot creates geometric unsharpness because rays originate across an area rather than at one point. Unsharpness increases with focal-spot size and object-to-detector distance relative to source-to-object distance. Magnification moves the breast away from the detector, making a smaller focal spot valuable for preserving fine detail. This geometric effect differs from motion blur and pixel sampling; improving one factor cannot automatically correct a limitation caused by another.
Apply it
A magnification setup increases the breast-to-detector distance to enlarge a calcification cluster. Select the appropriate small-focal-spot mode and maintain immobilization, recognizing that geometry and patient movement can independently reduce the visibility of tiny deposits.
Common pitfall: Electronic zoom does not change focal-spot geometry. A larger displayed image may still contain the same acquisition blur and cannot reveal detail that was never recorded.
IAEA: Quality Assurance Programme for Screen Film Mammography
14.How does an antiscatter grid trade contrast improvement against exposure?
An antiscatter grid preferentially absorbs scattered radiation before it reaches the detector, improving image contrast. It also absorbs some useful primary radiation, so maintaining detector exposure generally requires more incident exposure. Grid alignment and appropriate use therefore matter. Magnification techniques may use an air gap to reduce scatter reaching the detector instead. The relevant decision is how to control scatter for the acquisition geometry, rather than assuming that adding a grid always improves every examination.
Apply it
A trainee proposes using the contact-view grid arrangement unchanged for a magnification view. Explain the scatter-reducing role of the air gap and use the equipment's intended magnification configuration rather than improvising an additional grid.
Common pitfall: A grid cannot compensate for inadequate compression or motion. Contrast improvement must be considered together with exposure consequences and the manufacturer's supported acquisition arrangement.
IAEA: Quality Assurance Programme for Screen Film Mammography
15.What distinguishes direct from indirect digital x-ray conversion?
Direct-conversion detectors convert absorbed x-ray energy into electrical charge without an intermediate light stage. Indirect-conversion detectors first use a scintillator to produce light, then convert that light into an electrical signal. The distinction concerns detector physics, not whether the final image is digital. Detector design, sampling, efficiency, and noise all influence performance, so the conversion label alone does not establish which system will produce the better clinical image under a particular exposure.
Apply it
Two digital units use different detector designs. One includes a scintillator and photodiodes; the other uses a photoconductor. Identify the first as indirect conversion and the second as direct conversion before discussing their separate performance characteristics.
Common pitfall: Do not call indirect conversion 'film imaging.' Both designs produce digital signals, and both still depend on appropriate exposure, calibration, and clinically suitable image processing.
16.How does automatic exposure control depend on accurate acquisition conditions?
Automatic exposure control selects or terminates exposure using information related to breast thickness and transmitted x-rays, with implementation varying by equipment. Incorrect positioning, unsuitable sensing regions, or inaccurate thickness information can impair the relationship between selected technique and the tissue being imaged. AEC is therefore a tool within an acquisition process, not a replacement for positioning and technique review. Evaluate exposure information together with image noise and the breast's actual coverage.
Apply it
A routine image is unexpectedly noisy after an unusual positioning arrangement. Review breast coverage, indicated compressed thickness, and the system's selected technique before assuming that the detector has failed or that automatic exposure must always be correct.
Common pitfall: A correctly exposed region does not prove that all breast tissue is adequately imaged. AEC cannot restore tissue excluded from the detector by positioning.
17.Why can too few detected photons obscure subtle findings?
Quantum noise arises from statistical variation in detected x-ray photons. When fewer photons contribute to the image, relative fluctuations become larger and may obscure low-contrast structures. Increasing exposure can reduce this noise, but raises radiation dose and should not be used indiscriminately. The acquisition goal is sufficient signal for the clinical task at an appropriate dose. Distinguish random graininess from motion blur, fixed detector artifacts, and misleading display brightness before choosing a correction.
Apply it
A mammogram has acceptable displayed brightness but conspicuous random mottling that limits subtle tissue assessment. Review detector exposure and technique rather than attempting to solve the problem solely by increasing the monitor brightness or changing the display window.
Common pitfall: A smooth image is not proof that dose is optimized. Excess exposure can reduce noise while providing little additional diagnostic benefit once the clinical task is adequately supported.
18.Why is digital image brightness an unreliable guide to exposure?
Digital processing maps acquired detector signals into a display appearance, allowing images with different exposures to have similar brightness. This flexibility can conceal unnecessary exposure and contribute to dose creep. It also means that an underexposed image may look normally bright while remaining noisy. Review available exposure and dose information, image noise, and the clinical task together. Adjusting the display changes presentation; it does not replace photons or correct missing acquisition information.
Apply it
Two consecutive mammograms look equally bright, but one used substantially greater exposure for comparable conditions. Investigate the acquisition settings and dose information rather than accepting equal brightness as evidence that the exposures were equally appropriate.
Common pitfall: Do not use screen-film habits that equate image darkness directly with exposure. Digital processing can normalize appearance while leaving important noise or dose differences hidden.
19.How does tomosynthesis reduce the effect of overlapping tissue?
Digital breast tomosynthesis acquires multiple low-dose projections as the x-ray tube moves through an arc around the compressed breast. Reconstruction produces an image set that separates structures by depth, reducing the superimposition seen in a conventional projection. This helps distinguish actual abnormalities from overlapping normal tissue. DBT still uses ionizing x-rays and requires compression and stillness; depth separation does not eliminate all masking, motion, or positioning limitations.
Apply it
A patient asks how DBT differs from the previous two-dimensional examination. Explain that projections from different angles are reconstructed to separate tissue by depth, while the breast still needs to remain compressed and motionless during acquisition.
Common pitfall: Tomosynthesis is not ultrasound or MRI. Its reconstructed image set should not be described as radiation-free, and it cannot display breast tissue excluded during positioning.
20.What distinguishes synthesized two-dimensional images from separately acquired images?
A synthesized two-dimensional image is created computationally from tomosynthesis data rather than from a separate conventional two-dimensional exposure. A separately acquired image requires its own acquisition. Recognizing this distinction helps explain examination composition and radiation exposure without assuming that every DBT examination uses the same protocol. Both the reconstructed depth images and the accompanying projection-style images have defined roles; the local system and approved protocol determine which sets are obtained and reviewed.
Apply it
A patient sees a projection-style image after DBT and asks whether another x-ray was taken. Check the protocol and explain whether that image was synthesized from the DBT data or separately acquired.
Common pitfall: Do not infer acquisition history from image appearance alone. A projection-style image can be synthesized, and protocol differences prevent universal claims about the dose of every DBT examination.
21.How do viewing conditions affect detection of subtle mammographic detail?
Ambient light and reflections add unwanted luminance to the display, reducing perceived contrast, particularly in darker image regions. Clean screens, controlled lighting, and calibrated displays help preserve the visibility of subtle findings. Display quality assurance assesses whether the viewing system consistently presents the acquired information. A good acquisition cannot fully compensate for poor viewing conditions, and increasing room brightness or changing a window setting does not substitute for an appropriately maintained diagnostic display.
Apply it
A reading workstation faces a bright window and shows reflections across the breast images. Address the lighting and reflections and verify display quality before blaming the acquisition system for reduced visibility of subtle tissue differences.
Common pitfall: A sharper-looking image on an uncalibrated consumer screen does not establish diagnostic suitability. Display appearance must be evaluated with controlled conditions and applicable quality procedures.
22.Why must image identity and laterality remain reliable through transfer?
Digital images depend on correct patient identification, examination association, laterality, view labeling, and transfer to the intended archive or workstation. An anatomically adequate image attached to the wrong patient or labeled with the wrong side is clinically unsafe. Informatics checks therefore complement physical image evaluation. Confirm that all intended image sets arrive and remain correctly associated, especially when comparing prior examinations or transferring both tomosynthesis and projection-style images between systems.
Apply it
An imported prior examination appears under the correct patient but has inconsistent side labels. Resolve the discrepancy against reliable source information before treating the apparent side-to-side difference as a new anatomical finding.
Common pitfall: Do not silently relabel an image from visual intuition alone. Correcting identity or laterality requires reliable verification because an unsupported correction can create another error.
23.How do the two ACR mammography phantoms differ in accreditation acceptance criteria?
Both the small ACR Mammography Phantom and the ACR Digital Mammography Phantom simulate a 4.2-cm compressed breast of average density and contain fibers, speck groups, and masses. Fibers assess visibility of linear detail, specks represent calcification-like detail, and masses assess low-contrast structures. For ACR accreditation, the Digital Mammography Phantom must show the largest 2 fibers, 3 speck groups, and 2 masses. The small phantom must show the largest 4 fibers, 3 speck groups, and 3 masses. Neither may contain clinically significant artifacts. These accreditation criteria must be distinguished from manufacturer-specific routine QC requirements.
Apply it
An ACR Digital Mammography Phantom image shows its largest 2 fibers, 3 speck groups, and 2 masses without clinically significant artifacts: it meets the stated accreditation visibility criteria. The same counts on the small phantom would fail its fiber and mass criteria.
Common pitfall: Identify the phantom before interpreting its score. Applying the small phantom's 4/3/3 counts to the Digital Mammography Phantom, or treating accreditation counts as every manufacturer's routine QC limits, produces an incorrect conclusion.
Phantom Testing: Mammography (Revised 08-17-2026) : Accreditation Support
24.How does artifact location help identify its source?
An artifact that recurs at the same detector location across unrelated images suggests an equipment or calibration source rather than a breast lesion. External material may change after skin cleaning, while motion alters anatomical edges instead of producing a fixed detector pattern. Compare location, shape, and recurrence using appropriate quality-control images and clinical observations. Source identification should precede correction so that unnecessary patient repeats do not replace investigation of a persistent system problem.
Apply it
A narrow line appears at the same detector coordinate on images from several patients. Check an appropriate uniformity or artifact test and notify the responsible quality team rather than interpreting the line as repeated breast pathology.
Common pitfall: Repeating patient exposures without identifying a fixed system artifact adds dose and may reproduce the same defect. Cosmetic processing can also hide evidence needed for investigation.
25.How is a repeat-exposure rate calculated and interpreted?
The overall repeat rate is the number of repeated clinical exposures divided by the total number of clinical exposures during the period, multiplied by 100. Repeats address inadequate image quality; clinically indicated additional views are a different category. Analyze reasons such as positioning, motion, artifacts, or exposure errors to choose corrective action. A low rate alone does not prove quality, because unacceptable images could be retained instead of repeated or repeats could be incompletely recorded.
Apply it
A unit records 24 quality-related repeats among 1,200 total clinical exposures. Calculate 24 divided by 1,200 times 100, giving 2%. Review the reason distribution to determine whether positioning coaching or equipment investigation is needed.
Common pitfall: Do not divide repeats by patient count when the measure uses exposures. Do not count every diagnostic additional view as a failed acquisition requiring corrective action.
26.Which QC tasks distinguish technologist checks from physicist surveys and equipment evaluations?
These worked checks use the FDA-approved 2018 ACR Digital Mammography QC program, revised May 2020. Thickness: monthly, measure a dedicated smooth object 4–6 cm thick, no more than 10 cm long and no more than 10 cm wide. Center it laterally, flush with the chest-wall edge in contact mode. Use a spot paddle or the smallest nonflex paddle; disable flex if possible. Apply 10–15 lb compression, record indicated thickness, and release compression. Record indicated minus measured thickness; acceptance is ±5 mm. Recheck measurement and setup before repeating a failure; persistent failure requires service and correction within 30 days. See the ACR manual, Technologist Quality Control, [Compression Thickness Indicator: equipment, procedure, and performance criteria](https://www.acr.org/-/media/ACR/Files/Clinical-Resources/QC-Manuals/Mammo_QCManual.pdf). Force: semiannually, center a calibrated analog scale or dedicated force gauge between protective towels. Dedicated force-measuring tools may require modified procedures. Use manual fine adjustment to reach at least 25 lb, record the result, then release compression completely. Separately activate initial powered compression continuously while monitoring the measured force. If force exceeds 45 lb (200 N), immediately release compression and arrange appropriate service; excessive loading can damage the compression assembly. Do not continue waiting for automatic stopping after this limit is exceeded. Otherwise, record the force at the automatic stop; acceptance is 25–45 lb. Some sensor-controlled systems require additional pedal activation to measure maximum available force accurately. Follow the equipment-specific procedure within this ACR program while maintaining the immediate-release limit. Verify retention of at least 25 lb for the usual interval until an average exposure is completed or manual fine adjustment is engaged. If fine adjustment is engaged, verify that it then retains at least 25 lb through the usual duration of an average exposure. Record retention and release compression. Correct force failures before clinical use. See the ACR manual, Technologist Quality Control, [Compression Force: procedure steps 3–6 and performance criteria, including the immediate-release instruction on printed page 73](https://www.acr.org/-/media/ACR/Files/Clinical-Resources/QC-Manuals/Mammo_QCManual.pdf). Monthly monitor QC examines screen condition, test-pattern quality, and applicable automated tests. Display the prescribed pattern; check low-contrast insets and central/corner line pairs. Record each monitor's results. Significant blemishes preventing image assessment require correction before use; other test-pattern failures require correction within 30 days. The radiologist workstation also requires phantom-image assessment. Manufacturer calibration remains applicable within this ACR program: use its specified setup, sequence, frequency, and pass criteria, record completion, and correct failure before clinical use. The [ACR subcommittee update](https://amos3.aapm.org/abstracts/pdf/155-53832-1531640-165882.pdf) illustrates these responsibilities. Physicist work includes dose and AEC measurements, annual surveys, and review of technologist QC. A Mammography Equipment Evaluation is required after installation, disassembly/reassembly, or relevant major-component changes or repairs. Required failures must be corrected before affected equipment enters service.
Apply it
A smooth thickness object measures 50 mm thick, 80 mm long, and 80 mm wide; an indicated thickness of 57 mm gives a failing 7-mm error. During powered compression testing, a reading that rises above 45 lb requires immediate release and appropriate service, even if the system has not stopped automatically. A powered compression reading of 30 lb passes the initial-force range, but failure to retain at least 25 lb until fine adjustment, or through an average exposure after fine adjustment, fails retention. Document date, unit, operator, setup, measurements, acceptance decision, repeat results, and corrective action. Thickness and force have different correction deadlines. After an x-ray tube replacement, routine passing technologist checks do not replace the required physicist equipment evaluation; verify written passing results before patient examinations resume.
Common pitfall: These routine procedures and limits belong to the identified ACR alternative program; they are not universal manufacturer instructions or phantom accreditation-submission criteria. Release manual compression before separately testing initial powered compression. Monitor force throughout powered activation: automatic stopping does not justify allowing force to exceed 45 lb (200 N). Additional pedal activation on some sensor-controlled systems and modified procedures for dedicated gauges must respect this immediate-release condition. A passing initial powered-force reading does not establish adequate retention. Equipment model and software affect manufacturer programs. Routine QC does not replace an equipment evaluation, and verbal assurance does not replace required written evaluation results.
ARRT: Mammography Examination Content Specifications · Quality Control: Mammography (Revised 1-31-25) : Accreditation Support · 155-53832-1531640-165882.pdf
Procedures56.52% (65 of 115 scored questions)
27.What distinguishes the milk-producing lobules from the ducts?
Lobules are glandular structures involved in milk production, while ducts carry milk toward the nipple. This distinction provides the anatomical basis for terms such as lobular and ductal disease. A disease name identifies the relevant tissue compartment but does not alone describe whether abnormal cells remain confined or have invaded surrounding tissue. Combine the structure of origin with the pathological description when interpreting terminology, rather than treating all breast glandular structures as interchangeable.
Apply it
A pathology report describes abnormal cells within a milk duct. Identify the duct as the transport structure and look for whether the report describes confinement or invasion before inferring the disease's relationship to surrounding tissue.
Common pitfall: Ductal and lobular describe anatomical origin, while in situ and invasive describe spread relative to the originating structure. These distinctions answer different clinical questions.
28.How do fat, connective tissue, and pectoral muscle relate anatomically?
The breast contains glandular tissue, connective supporting tissue, and fat and rests on the pectoralis major muscle of the chest wall. The breast itself is not a muscle. These relationships help explain mammographic tissue appearance and why chest-wall positioning matters for posterior coverage. Fat surrounding glandular structures can help define their boundaries, while pectoral muscle seen on a projection is a positioning landmark rather than evidence that the breast consists of muscle.
Apply it
A trainee calls the pectoral region on an MLO image 'breast muscle.' Clarify the chest-wall relationship and use the muscle together with posterior breast landmarks to discuss whether the positioning includes sufficient deep tissue.
Common pitfall: Visible pectoral muscle is useful but does not independently prove complete breast coverage. Anatomy must be assessed across the breast rather than reduced to one landmark.
29.Which lymph node regions are associated with the breast?
Breast lymphatic pathways connect with regional nodes including axillary, internal mammary, and supraclavicular groups. Lymph nodes filter lymph and participate in immune function; their relationship to the breast is also important in cancer staging. A visible or enlarged node does not establish metastatic disease by itself. Recognize the regional anatomy and communicate relevant findings or symptoms while leaving diagnosis and staging to the responsible clinical team and appropriate tissue or imaging assessment.
Apply it
A patient reports a new lump in the ipsilateral axilla during breast imaging. Record the location and communicate it as a regional concern requiring assessment rather than assuming it is unrelated to the breast.
Common pitfall: Do not label every axillary node as metastatic or assume that all breast drainage is exclusively axillary. Regional anatomy is broader than a single nodal group.
30.Why can hormonal state change breast tissue and examination comfort?
Breast tissue responds to hormones including estrogen, progesterone, and prolactin, with changes across the menstrual cycle, pregnancy, and lactation. These influences can affect glandular development, tissue fullness, and tenderness. Hormone history therefore contributes to understanding the patient's current condition and comfort needs. It does not establish that a focal abnormality is harmless. Use the history to contextualize imaging and positioning while maintaining appropriate evaluation of new localized symptoms.
Apply it
A patient describes predictable breast tenderness before menstruation and has no new focal symptom. Explain how scheduling routine screening when tenderness is lower may improve comfort, while documenting relevant hormone use for the interpreting team.
Common pitfall: Cyclical tenderness should not be used to dismiss a distinct new lump or persistent focal change. General hormonal explanations cannot replace assessment of a specific concern.
NCI SEER Training: Breast Anatomy · ACR/RSNA RadiologyInfo: Mammography
31.Why does breast density affect both visibility and cancer risk?
Dense breasts contain relatively more glandular and fibrous tissue and less fat. Dense tissue appears light on mammograms, as many cancers do, so it can mask abnormalities and reduce mammographic sensitivity. Density is also independently associated with greater breast cancer risk. These are separate effects: difficulty seeing a cancer and a greater likelihood of developing one. Density is assessed from imaging rather than breast size, firmness, or the patient's own physical impression.
Apply it
A patient with small breasts is surprised by a dense-breast report. Explain that density concerns internal tissue composition, not size, and that the report supports discussion of individual risk and possible supplemental imaging with her clinician.
Common pitfall: Dense tissue is not itself a cancer diagnosis. A negative mammogram in dense breasts also does not prove that a newly reported clinical abnormality is absent.
32.How should a breast location be described consistently?
Breast locations can be described by laterality, quadrant, or clock position, with the nipple providing a reference point. Reliable localization supports communication between mammography, ultrasound, clinical examination, and intervention. A clock position without the breast side is incomplete because medial and lateral relationships differ between breasts. Include enough detail to distinguish the concern from another finding, and preserve the reference system rather than substituting image orientation for anatomical location.
Apply it
A patient indicates a right breast lump near the outer side. Document the breast and a consistent quadrant or clock description, then communicate the location so any targeted imaging addresses the same reported area.
Common pitfall: Do not record only 'three o'clock' without laterality. A finding's location on the displayed image is also not automatically its anatomical position within the breast.
NCI SEER Training: Breast Anatomy · ACR/RSNA RadiologyInfo: How to Read Your Breast Imaging Report Using BI-RADS
33.What separates ductal carcinoma in situ from invasive disease?
Ductal carcinoma in situ consists of abnormal cells confined within breast ducts, without spread into surrounding breast tissue. Invasive disease has extended beyond the originating compartment into adjacent tissue. The defining distinction is pathological confinement, not whether a lesion is palpable or visible as calcifications. Imaging can identify findings that need assessment, but tissue evaluation establishes the relevant cellular and invasion features. Avoid inferring invasion solely from the size or apparent conspicuity of an imaging finding.
Apply it
A biopsy report describes DCIS in tissue sampled from a calcification cluster. Explain that the term indicates duct-confined disease in the assessed tissue, rather than assuming the mammographic calcifications themselves demonstrate invasive spread.
Common pitfall: In situ does not mean that no treatment or follow-up is needed. Conversely, an impalpable finding is not automatically in situ; palpability does not define invasion.
34.How does ultrasound help distinguish fluid from solid breast findings?
Ultrasound uses reflected sound waves to assess a breast finding's internal structure and can help determine whether it contains fluid, solid tissue, or both. This is useful when a mammographic or palpable finding needs further characterization. The fluid-versus-solid distinction informs assessment but is not a complete benign-versus-malignant classification. Solid masses may be benign, and complex findings require evaluation of their full features and correlation with the clinical and other imaging information.
Apply it
A rounded mammographic finding needs characterization. Targeted ultrasound demonstrates its internal contents and relationship to the reported location, helping the radiologist distinguish a fluid-filled structure from a solid mass before assigning management.
Common pitfall: Do not equate every solid mass with cancer or every fluid-containing finding with a simple benign cyst. Internal complexity and imaging correlation still matter.
35.How do mass shape, margins, and density distinguish reassuring from suspicious features?
Describe a mammographic mass by shape, margin, and density relative to an equal volume of fibroglandular tissue. A circumscribed margin has a sharp boundary; an obscured margin is hidden by overlapping tissue; an indistinct margin lacks a clear boundary; spiculation consists of radiating lines. Irregular shape, indistinct margins, and spiculation raise concern. Fat-containing masses commonly have benign causes such as lipoma or oil cyst. A fibroadenoma contains fibrous and glandular tissue, whereas a lipoma contains fat. A circumscribed nonfat mass cannot be classified as fibroadenoma from its outline alone. These features guide assessment rather than establish histology. [UCLA mass examples](https://www.uclahealth.org/departments/radiology/education/breast-imaging-teaching-resources/birads/mammography-masses).
Apply it
Compare a circumscribed fat-containing mass with an irregular high-density mass having radiating margins. Identify fat content as a reassuring discriminator in the first and spiculation plus irregular shape as suspicious in the second; neither comparison authorizes an independent pathological diagnosis.
Common pitfall: Obscured and indistinct are different: hidden tissue may need separation, while a genuinely ill-defined boundary remains concerning. Mass density also differs from the patient's overall breast-density category.
ARRT: Mammography Examination Content Specifications · NCI: Benign and Precancerous Breast Lumps and Conditions
36.How do calcification morphology and distribution change the level of concern?
Assess both the appearance of individual deposits and their arrangement. Typically benign patterns include parallel vascular tracks, coarse popcorn-like deposits, and rim calcification around an oil cyst. Suspicious morphologies include amorphous, coarse heterogeneous, fine pleomorphic, and fine linear or branching deposits. Fine pleomorphic deposits vary in shape and size; fine linear or branching deposits can outline ductal contents. Linear or segmental distribution suggests a ductal arrangement; diffuse distribution spreads deposits throughout the breast. Grouping alone does not establish malignancy. Combine morphology, distribution, and change over time rather than treating all small deposits alike. [UCLA calcification examples](https://www.uclahealth.org/departments/radiology/education/breast-imaging-teaching-resources/birads/mammography-calcifications).
Apply it
Compare bilateral vascular tracks with new fine pleomorphic deposits arranged along a branching path. Identify the vascular morphology as typically benign and the variable fine shapes plus ductal distribution as suspicious features requiring assessment, without calling the latter DCIS from imaging alone.
Common pitfall: Coarse popcorn-like and coarse heterogeneous are different descriptors. A benign explanation for one pattern does not make every coarse deposit benign, and a grouped pattern needs its morphology evaluated.
37.How do atypical hyperplasia and LCIS alter risk interpretation?
Atypical ductal and lobular hyperplasia describe increased numbers of abnormal-looking cells in their respective compartments. Lobular carcinoma in situ describes abnormal cells within lobules and increases the risk of cancer in either breast. These findings should not be treated as equivalent to an established invasive cancer diagnosis. Their importance includes future risk and appropriate surveillance planning. Preserve the specific pathological terminology because tissue compartment, degree of abnormality, and risk implications differ.
Apply it
A patient with classic LCIS in the left breast assumes only that breast needs future attention. Explain that LCIS is associated with increased cancer risk in either breast and reinforce the individualized surveillance plan.
Common pitfall: The word carcinoma in LCIS does not make it interchangeable with invasive carcinoma. Also avoid treating atypical hyperplasia as ordinary tissue variation without risk implications.
38.How can fat necrosis or a surgical scar resemble suspicious architectural distortion?
Fat necrosis is a benign process caused by damaged fatty tissue, potentially after injury, surgery, or radiation. It can produce a lump or an imaging finding requiring assessment. Architectural distortion describes disruption of the normal tissue pattern, with radiating lines or focal retraction and no definite central mass. Scars and benign fibrosing processes can cause distortion, but malignancy can also produce it. Persistence on appropriately targeted diagnostic images supports a real structural finding rather than simple overlap. Correlate its exact location and evolution with treatment history and prior images; history alone cannot establish benignity. [UCLA architectural-distortion examples](https://www.uclahealth.org/departments/radiology/education/breast-imaging-teaching-resources/birads/architectural-distortion).
Apply it
Radiating tissue lines persist on spot-compression images outside the documented surgical site. Recognize architectural distortion and explain why the unrelated scar history does not account for it. Communicate the location and persistence for diagnostic assessment.
Common pitfall: A benign mechanism does not make every post-traumatic lump or distortion benign. Conversely, distortion is an imaging descriptor, not proof of invasive cancer.
NCI Dictionary: Fat Necrosis · ARRT: Mammography Examination Content Specifications
39.When should persistent nipple or areolar changes raise concern for Paget disease?
Paget disease of the breast involves the nipple and often the areola and can cause changes such as redness, scaling, crusting, itching, or discharge. These features can resemble common skin conditions, so persistent changes deserve clinical evaluation rather than an assumed dermatological explanation. The symptom pattern identifies an area needing assessment; it does not establish the diagnosis. Accurate documentation of laterality, duration, and progression helps correlate the clinical concern with imaging and examination.
Apply it
A patient reports persistent unilateral nipple crusting that has not resolved. Document the duration and affected area and communicate the concern for clinical evaluation, even if the patient initially describes it as ordinary eczema.
Common pitfall: Do not diagnose Paget disease from appearance alone. Equally, do not dismiss persistent nipple changes solely because itching or scaling can occur with benign skin disorders.
41.What makes a craniocaudal view anatomically adequate?
A craniocaudal view should include medial and lateral breast tissue with adequate posterior depth, avoiding rotation that sacrifices one side. Assess the nipple, posterior tissue landmarks, and complementary MLO coverage together. Pectoral muscle may appear but is not required on every adequate CC image. Retroglandular fat supports posterior assessment when present; in breasts with little visible fat, assess fibroglandular depth and compare prior adequate images. The ACR positioning improvement criterion requires nipple profile on at least one standard view of each breast, rather than both. Remove obscuring folds and projected body parts while preserving tissue inclusion.
Apply it
A CC image has an off-center nipple and missing medial tissue. Correct patient rotation and placement to recover the omitted region. If posterior fat is minimal, compare fibroglandular depth and the MLO image rather than judging coverage from a nonexistent fat plane.
Common pitfall: A centered nipple or adequate exposure alone does not establish complete coverage. Absence of pectoral muscle or retroglandular fat alone does not establish failure, and nipple profile must not be obtained by sacrificing tissue.
42.How should the MLO view balance pectoral, axillary, and inferior coverage?
The mediolateral oblique view should include posterior and axillary tissue, with the inferior breast lifted to demonstrate an open inframammary fold. Pectoral muscle is a useful landmark, ideally broad superiorly and narrowing inferiorly toward the posterior nipple line. Broad muscle visibility alone does not prove complete breast coverage. A closed fold can hide inferior tissue; large skin folds or the chin, shoulder, hand, or opposite breast can obscure other regions. Judge folds by their effect on tissue visibility, distinguishing a small nonobscuring fold from substantial overlap. Before exposure, check obstructions without pulling breast tissue off the detector.
Apply it
An MLO image includes broad pectoral muscle but omits the axillary tail and closes the inframammary fold. Reassess detector placement and breast lift, smooth obscuring folds, and keep the chin clear while confirming that posterior tissue remains included.
Common pitfall: Exposure or display processing cannot separate tissue already superimposed by a fold or body part. Correcting inferior coverage must not sacrifice posterior or axillary inclusion.
43.How does posterior nipple line comparison flag a coverage concern?
The ACR positioning improvement resource uses a criterion that the CC posterior nipple line should be within 1 cm of the MLO posterior nipple line. The line is measured from the nipple base toward the pectoralis at a right angle, with the skin line used when the nipple is rolled. A larger discrepancy flags a positioning review. This is a quality-improvement criterion, not an accreditation rule or an automatic mandate to repeat every discrepant image.
Apply it
The CC posterior nipple line measures 8.0 cm and the MLO line measures 9.4 cm. Calculate a 1.4 cm difference, identify a review concern under this criterion, and inspect posterior coverage and the measurement conditions.
Common pitfall: Do not convert the measurement into an automatic repeat decision. Incorrect measurement, anatomical limitations, and the rest of the image assessment can change the appropriate response.
44.How does a true lateral view help localize a finding?
A true lateral uses a horizontal beam with the detector at 90 degrees to the CC orientation, demonstrating superior-inferior position without the MLO's obliquity. In ML, the beam enters medially and the detector is lateral; LM reverses that arrangement. Placing the target closer to the detector limits object-to-detector distance. Correlate target position with CC and MLO landmarks and verify that the expected region is included before using the lateral image for localization. [Siemens positioning illustrations](https://academy.siemens-healthineers.com/_/en-us/xp-and-wh-education-mammography-positioning/).
Apply it
A medial finding needs a true lateral acquisition. Use the LM geometry to place medial tissue nearer the detector, include the relevant posterior depth, and confirm the same finding using its nipple relationship and surrounding landmarks.
Common pitfall: An MLO image is oblique and cannot substitute for a true lateral when the task requires a 90-degree projection. Failure to see a target is inconclusive if its region was excluded.
ARRT: Mammography Examination Content Specifications · IAEA: Quality Assurance Programme for Screen Film Mammography
45.When does an exaggerated CC view address missing peripheral tissue?
An exaggerated CC retains a superior-to-inferior projection but changes patient rotation and detector contact to bring deep lateral tissue onto the receptor for XCCL or deep medial tissue for XCCM. Its purpose is peripheral coverage rather than depth reconstruction. Verify the intended posterior region and correlate it with the original view; the opposite edge may be sacrificed. [Siemens exaggerated-CC illustrations](https://academy.siemens-healthineers.com/_/en-us/xp-and-wh-education-mammography-positioning/).
Apply it
A posterior lateral density appears on MLO but its expected region is outside the standard CC field. Obtain the requested XCCL, confirm inclusion of deep lateral tissue, and compare anatomical landmarks before concluding whether the density has a CC correlate.
Common pitfall: An exaggerated view supplements standard coverage. A negative image that still excludes the posterior target does not resolve the finding.
46.How does a tangential view test whether a finding lies in the skin?
A tangential view directs the beam along the skin surface at a localized finding, bringing the skin and underlying fat into profile. Mark the relevant skin site and adjust breast or C-arm position so that the beam is tangent there. Verify that the marker and intended finding lie at the demonstrated skin contour. This can distinguish a dermal deposit or lesion from one within the breast. [UCLA skin-lesion example](https://www.uclahealth.org/departments/radiology/education/breast-imaging-teaching-resources/cases/case-skin-lesion).
Apply it
Calcifications appear near the breast surface. Localize and mark the suspected skin site, obtain a tangential projection, and check whether the deposits coincide with the skin profile rather than remaining within deeper parenchyma.
Common pitfall: A correctly profiled marker does not prove that an uncorrelated deeper finding is dermal. The image must demonstrate the actual target at the skin.
47.How do rolled views distinguish tissue overlap from a persistent finding?
Rolled views change breast-tissue position while retaining the projection's beam direction. For rolled CC views, move superior tissue medially or laterally while inferior tissue moves oppositely. This separates structures previously superimposed and can clarify a one-view asymmetry or an obscured margin. Compare the expected target region and surrounding landmarks after rolling; disappearance supports summation only when that region remains included. [Primary study of rolled views](https://pmc.ncbi.nlm.nih.gov/articles/PMC2978743/).
Apply it
An apparent density is visible only on CC. Obtain requested rolled medial and lateral CC views, document the rolling direction, and verify coverage of the original region. If the density separates into normal tissue, overlap is supported; persistence requires further characterization.
Common pitfall: Rotating the x-ray beam is different from rolling tissue. A finding that leaves the field has not been shown to disappear through tissue separation.
48.What distinguishes asymmetry, focal asymmetry, and developing asymmetry?
An asymmetry is increased tissue density seen on one projection without confirmed mass features. A focal asymmetry is seen on two projections but lacks the defined three-dimensional appearance of a mass. A developing asymmetry is new, larger, or more conspicuous than on prior examinations and is more concerning. Overlapping tissue can create an apparent asymmetry, so additional views or DBT assess persistence and localization. Compare equivalent regions and acquisition coverage before interpreting an apparent change. [UCLA asymmetry examples](https://www.uclahealth.org/departments/radiology/education/breast-imaging-teaching-resources/birads/breast-asymmetry).
Apply it
A focal density persists on CC and MLO and is larger than on prior adequately positioned images. Identify focal asymmetry with a developing change, and explain why the temporal increase matters more than merely seeing unequal tissue between breasts.
Common pitfall: A one-view density is not automatically a mass or a summation artifact. Developing asymmetry is an imaging concern rather than a pathological diagnosis, and stable asymmetry still needs its full features assessed.
ARRT: Mammography Examination Content Specifications · ACR/RSNA RadiologyInfo: How to Read Your Breast Imaging Report Using BI-RADS
49.How does focused compression help evaluate a localized finding?
Focused compression applies pressure to a smaller region, spreading superimposed tissue around a localized finding and improving assessment of its persistence and boundaries. This is a diagnostic application of the same tissue-separation principle used in standard mammography. The suspicious region must be included accurately; a sharply compressed image of the wrong area does not answer the question. The radiologist integrates the result with other views and modalities rather than assigning benignity from compression behavior alone.
Apply it
A screening image shows a focal area that may reflect overlapping tissue. For the requested diagnostic view, position the identified region under the focused paddle and verify its inclusion so the radiologist can assess the actual finding.
Common pitfall: A finding that becomes less conspicuous under compression is not automatically harmless. Confirm that the intended region was imaged and interpret its behavior within the complete assessment.
ACR/RSNA RadiologyInfo: Mammography · IAEA: Quality Assurance Programme for Digital Mammography
50.Why is geometric magnification useful for fine calcification detail?
Geometric magnification enlarges the projected image by increasing the object's distance from the detector. It can support assessment of small calcifications, provided the acquisition uses appropriate small-focal-spot technique and immobilization. The air gap also changes scatter conditions. This differs from enlarging existing pixels on a workstation: geometric magnification changes acquisition geometry, whereas electronic zoom changes display size. Fine-detail assessment depends on preserved sharpness, so enlargement alone is not sufficient.
Apply it
A radiologist requests magnification of a small calcification cluster. Center the target in the intended geometry, use the supported small-focal-spot mode, and explain stillness so acquisition blur does not erase the detail the view is meant to show.
Common pitfall: Do not substitute routine electronic zoom when a dedicated magnification acquisition is requested. Enlarging an already blurred image does not restore the missing fine detail.
IAEA: Quality Assurance Programme for Screen Film Mammography
51.How should limited mobility alter mammographic positioning decisions?
Limited shoulder movement, balance difficulty, pain, or inability to stand can change how safely a patient reaches the detector. Assess the limitation before forcing the standard posture, then adapt support and equipment positioning within the system's capabilities. The imaging goals remain tissue inclusion, tolerable compression, and stillness. Document material limitations so the interpreting team understands what was achievable. The examination's quality should be judged from actual coverage, rather than from how closely the patient's posture resembles a routine demonstration.
Apply it
A patient cannot maintain an unsupported standing position. Use an appropriate supported arrangement, assess comfort and detector access, and review tissue coverage after acquisition instead of requiring the patient to stand through repeated unstable attempts.
Common pitfall: Forcing a standard posture can worsen pain and motion. An adapted posture is not automatically inadequate, but its images still need careful evaluation for missing tissue.
ARRT: Mammography Examination Content Specifications · ACR/RSNA RadiologyInfo: Mammography
52.When are multiple coverage images different from quality-related repeats?
A breast larger than the detector may need planned overlapping images to cover tissue that cannot fit into one acquisition. These images serve anatomical coverage and differ from repeated exposures taken because an image was inadequate. Map what each image includes so no region is omitted and the interpreting team can relate the views. The IAEA digital repeat-analysis method excludes necessary coverage images from quality-related repeats, preserving the distinction between required imaging and avoidable acquisition failure.
Apply it
A large breast cannot be fully included in one CC acquisition. Plan complementary coverage with identifiable overlap and review the combined tissue inclusion, rather than squeezing the breast into a single image that omits a posterior region.
Common pitfall: Do not count every extra coverage image as a positioning failure. Conversely, labeling an image 'coverage' does not excuse avoidable cutoff or a gap between the images.
53.How do implant-displacement views expose tissue, and what can limit the maneuver?
Breast implants can obscure tissue because their contents are not transparent to x-rays. Implant-displacement views move the implant posteriorly toward the chest wall while breast tissue is drawn forward and compressed separately, improving visualization anterior to the implant. Scar-related capsular contracture can make displacement difficult and uncomfortable; displacement is generally easier when the implant lies behind the chest muscle. Assess implant history and tolerance, use experienced technique, and document limitations. Implant displacement improves coverage but does not remove every implant-related limitation.
Apply it
A patient asks why additional views are needed but has a firm, painful implant. Explain the tissue-separation goal, reassess displacement with experienced personnel, and document what could be achieved rather than repeatedly increasing pressure.
Common pitfall: Displacement is not firmer compression of the implant-containing breast as a unit. Contracture limits mobility, and forceful manipulation cannot be treated as a universal solution.
54.What preparation and aftercare make image-guided breast biopsy safer?
Before biopsy, verify patient identity, intended procedure, breast side, and the imaging-defined target; confirm documented informed consent and complete the team time-out before starting. Review anticoagulants, antiplatelet drugs, supplements, bleeding history, and allergies, especially to local anesthesia. Communicate bleeding risk to the procedural clinician, who determines individualized medication instructions; there is no universal anticoagulant hold. After sampling, apply pressure for hemostasis, dress the site, and provide written instructions for wound care, activity, warning symptoms, contact details, and results follow-up. Stereotactic-biopsy advice includes avoiding strenuous activity for at least 24 hours and reporting excessive bleeding, swelling, redness, drainage, or warmth.
Apply it
The consent names a right-breast target, but the scheduled procedure lists the left breast and the patient reports an anticoagulant plus anesthetic allergy. Pause before needle insertion, reconcile side and target during verification, and obtain clinician-directed medication and allergy plans. Before discharge, confirm understanding of bleeding instructions and whom to contact.
Common pitfall: A signed form does not resolve a target discrepancy or replace the time-out. Do not independently stop anticoagulants, and do not discharge a patient without a clear aftercare and results plan.
ARRT: Mammography Examination Content Specifications · ACR/RSNA RadiologyInfo: Stereotactic Breast Biopsy
55.When is ultrasound guidance useful for breast needle sampling?
Ultrasound can display a target and needle in real time without ionizing x-rays, making it useful for sampling a lesion that is clearly visible sonographically. Guidance selection depends on which modality reliably demonstrates the intended abnormality and supports safe access. A mammographic finding that is not visible on ultrasound cannot be assumed to have been sampled merely because a nearby sonographic structure was targeted. Correlation between the target and the original finding is essential.
Apply it
A mammographic mass has a clear corresponding ultrasound target. The procedural team can use real-time ultrasound to monitor needle approach, while confirming that the sampled structure is the same lesion identified on the mammogram.
Common pitfall: Do not select ultrasound guidance solely because it avoids radiation. The actual target must be visible and convincingly correlated, especially when the original concern is mammographic calcifications.
56.What makes breast MRI a distinct imaging modality?
Breast MRI uses a strong magnetic field, radiofrequency energy, and computer processing to create images; it does not use ionizing x-rays. It can provide information that complements mammography and ultrasound for selected clinical indications. This mechanism introduces its own screening and safety considerations, including implanted-device compatibility and contrast-related assessment when contrast is planned. MRI's absence of x-rays does not mean that every patient is suitable or that it replaces mammography for every clinical question.
Apply it
A patient asks whether an MRI adds more x-ray exposure after mammography. Explain the magnetic and radiofrequency mechanism, then ensure that relevant implant and contrast history is assessed through the MRI safety process.
Common pitfall: Do not confuse MRI's radiation mechanism with DBT's x-ray acquisition. Radiation-free imaging still requires modality-specific safety screening and an indication that the examination can answer.
57.How do stereotactic images establish a three-dimensional biopsy target?
Stereotactic mammography obtains images from different angles and uses the target's positional differences to calculate coordinates for needle placement. This adds depth information to the target's apparent projection location. Compression stabilizes the breast so those coordinates remain relevant during the procedure. Confirmatory imaging checks needle position before sampling. The calculated coordinates support targeting but do not establish that the retrieved tissue contains the intended abnormality; specimen verification may still be necessary.
Apply it
A calcification cluster is selected for stereotactic sampling. Maintain stable breast positioning during angled imaging and needle placement, and support the confirmatory images needed to verify the needle's relationship to the target before tissue collection.
Common pitfall: Do not treat one projection location as complete depth information. Movement after coordinate calculation can also invalidate targeting even when the original images were technically adequate.
58.Why are biopsy specimens imaged when calcifications are the target?
Specimen radiography checks whether tissue removed during a calcification-targeted biopsy contains the intended deposits. It links the imaging target to the tissue sent for pathological examination. If the specimen lacks the target calcifications, additional sampling may be needed under the procedural clinician's direction. This check addresses sampling adequacy, not the final benign or malignant diagnosis. Accurate initial needle placement and successful marker deployment do not independently prove that the target deposits were retrieved.
Apply it
Needle-position images appear satisfactory, but the specimen image shows no target calcifications. Alert the procedural radiologist before concluding the sampling, allowing assessment of targeting and whether additional tissue should be collected.
Common pitfall: Do not accept a marker image as proof that calcifications were sampled. Marker position, needle position, specimen contents, and pathological diagnosis answer separate questions.
59.What distinguishes a biopsy marker from a preoperative localization wire?
A biopsy marker identifies the sampled site for later imaging or treatment planning, and postprocedure imaging can document its position. A localization wire helps a surgeon find an imaging-defined area that may not be palpable before surgical removal. Both support location, but their timing and purposes differ. Neither proves malignancy or guarantees target retrieval. Match the device to the clinical task: preserving the location of a sampled site versus directing surgery to a specific abnormal area.
Apply it
A patient with a nonpalpable lesion is scheduled for surgery and asks whether the biopsy marker and planned wire serve identical purposes. Explain that the marker identifies the prior sampling site, while localization guides the surgeon to the intended area.
Common pitfall: Do not treat a localization wire as a diagnostic biopsy result. A marker also should not be presented as proof that the sampled tissue contained the target.
NCI Dictionary: Needle Localization · ACR/RSNA RadiologyInfo: Stereotactic Breast Biopsy
60.How should contaminated sharps be contained after breast procedures?
Under the applicable U.S. OSHA bloodborne pathogens standard, contaminated sharps belong in containers that are closable, puncture resistant, leakproof on the sides and bottom, and appropriately labeled or color coded. Containers should be accessible near use, maintained upright, and replaced before overfilling. Prompt disposal reduces handling and needlestick risk. Gloves do not eliminate puncture hazards, so safe containment and avoidance of unnecessary manipulation remain essential after a biopsy or other needle procedure.
Apply it
After a breast biopsy, the used needle needs disposal and the nearby container is nearly full. Use an appropriate available sharps container and arrange replacement before overfilling, keeping the contaminated needle out of ordinary waste.
Common pitfall: Do not place contaminated needles in regular trash or manipulate them to save container space. Protective gloves are a barrier against exposure, not reliable protection from puncture.
What to focus on during revision
The following are CertMedbry study suggestions. Use the official outline to check the full scope of your examination.
- Give Procedures the largest study share, while separately reviewing its anatomy/pathology and positioning/procedure components.
- Evaluate standard-view tissue inclusion, then match true lateral, exaggerated CC, tangential, rolled, spot-compression, or magnification views to a specific coverage or localization problem.
- Compare mass shape, margins, and density; distinguish asymmetry from distortion; and evaluate calcification morphology together with distribution and change over time.
- Distinguish acquisition noise, geometric blur, motion, external artifacts, detector artifacts, and display limitations before choosing a correction.
- Identify the phantom before applying its accreditation criteria, and distinguish technologist checks, annual physicist surveys, and equipment-evaluation triggers.
- Explain screening versus diagnostic indications, compression, density, and follow-up in language a patient can understand.
- Connect biopsy verification, consent, time-out, medication and allergy review, sampling checks, and aftercare; separate imaging evidence from pathological diagnosis.
- Use current applicable U.S. MQSA requirements and equipment-specific QC procedures; older IAEA manuals support enduring technical principles.
A practical preparation plan
1. Map the complete official scope
Read the official examination specifications and mark topics beyond these 60 selected concepts. Allocate initial study time using the 20:30:65 scored-question distribution, then adjust for your own weaknesses.
2. Build anatomy-to-positioning explanations
Explain standard-view coverage, then choose additional views for missing peripheral tissue, superior-inferior localization, suspected dermal findings, and tissue overlap. State the beam and tissue geometry and how you will verify inclusion of the intended region.
3. Diagnose image-quality problems
Sort examples by noise, motion, geometric unsharpness, overlap, artifact, and display conditions. Calculate repeat rates, interpret specified phantom results, and distinguish routine QC from annual surveys and evaluations after equipment changes.
4. Describe findings before assigning meaning
Compare circumscribed fat-containing and spiculated masses, stable and developing asymmetries, persistent distortion, and benign versus suspicious calcification patterns. Explain which feature changes concern and why imaging descriptors do not establish histology.
5. Practise patient and procedural decisions
Rehearse responses to symptoms, pain, density, pregnancy, and imaging assessments. Walk through biopsy preparation, consent, time-out, bleeding-risk and allergy review, target verification, specimen imaging, and postprocedure instructions.
6. Use drills to expose reasoning gaps
Complete the 20 questions without notes, then explain why each alternative is less appropriate. Review flashcards after a delay and revisit the official outline for any topic you cannot explain accurately.
Use your sample score as a starting point
The free set contains 20 original practice questions. It is a small learning sample, not an official examination or a validated pass prediction. Review each explanation and its source before moving to another topic.
Start the free sampleOfficial sources and updates
- ARRT: Mammography
- ARRT: Reference Documents by Discipline
- ARRT: Examination Content Specifications
- ARRT: Mammography Examination Content Specifications
- FDA: Frequently Asked Questions About MQSA
- ACR/RSNA RadiologyInfo: Mammography
- ACR/RSNA RadiologyInfo: Breast Tomosynthesis
- NCI: Dense Breasts—Answers to Commonly Asked Questions
- IAEA: Quality Assurance Programme for Screen Film Mammography
- IAEA: Quality Assurance Programme for Digital Mammography
- NCI SEER Training: Breast Anatomy
- NCI: Ductal Carcinoma in Situ
- NCI: Benign and Precancerous Breast Lumps and Conditions
- ACR/RSNA RadiologyInfo: How to Read Your Breast Imaging Report Using BI-RADS
- ACR: Mammography Positioning Review Guidelines Table
- American Cancer Society: Mammograms with Breast Implants
- ACR/RSNA RadiologyInfo: Breast Ultrasound
- NCI Dictionary: Needle Localization
- ACR/RSNA RadiologyInfo: Stereotactic Breast Biopsy
- NCI: Breast Cancer Causes and Risk Factors
- NCI: Lumpectomy
- NCI: Paget Disease of the Breast
- NCI Dictionary: Fat Necrosis
- ACR/RSNA RadiologyInfo: Breast MRI
- OSHA: Bloodborne Pathogens Standard, 29 CFR 1910.1030
- arrt-postprimary-handbook.pdf
- Quality Control: Mammography (Revised 1-31-25) : Accreditation Support
- Phantom Testing: Mammography (Revised 08-17-2026) : Accreditation Support
- Mammography: Masses - Radiology | UCLA Health
- Mammography: Calcifications - Radiology | UCLA Health
- Architectural Distortion - Radiology | UCLA Health
- Breast Asymmetry - Radiology | UCLA Health
- Case: Skin Lesion - Radiology | UCLA Health
- 155-53832-1531640-165882.pdf
- An Effective Way to Solve Equivocal Mammography Findings: The Rolled Views - PMC
- Medical Physics Resources
Confirm current eligibility, fees, scheduling and policies directly with the examination provider. CertMedbry is independent and is not endorsed by these organisations. How we handle content and corrections.